DexCom, Inc. (DXCM) fair value analysis
S&P 500 & Nasdaq · Updated 2026-08-30
Forward Fair Value verdict
UndervaluedBased on TickrTrends' weekly Forward Fair Value model, DXCM is trading at more than a 25% discount to estimated fair value.
- Last price
- $90.82
- Sector
- Healthcare
- 12-month range
- $58.22–$87.31
What our data shows for DXCM
- Our model validated 12 trailing price-to-earnings windows for DXCM, built from quarterly earnings records.
- Shares are trading in the upper third of their 12-month price range of $58.22–$87.31.
- The 14-day relative strength index sits at a neutral 70.
- 4 of the last 12 weekly snapshots showed positive price momentum.
The exact numbers are one step away
- The precise Forward Fair Value dollar figure for DXCM
- Exact discount / premium to today's price
- The normalized historical P/E behind the estimate, and how many quarters support it
- Forward EPS input and fiscal-year basis
- Screeners and rankings across the full S&P 500 and Nasdaq universes
How Forward Fair Value works
TickrTrends computes a Forward Fair Value for every covered stock each week: a conservatively normalized historical price-to-earnings multiple is applied to the analyst-consensus earnings estimate for the next full fiscal year. Every input window is validated for continuity and every result is screened for plausibility before publication.